Core Scientific, Inc. CORZ Change in fair value of contingent value rights

Change in fair value of contingent value rights at other companies

IlluminaILMN

-$16M-45.5%

Riot Platforms, Inc.RIOT

-$430K+30.1%

InsmedINSM

-$46.96M-357%

Globus MedicalGMED

$6.35M+3,704%

The Carlyle GroupCG

$0-100%

Brown & BrownBRO

$5M+225%

Other financials

Income statement

See full

Revenue$115.2M+44.9%

Gross profit$30.1M+267%

Operating income-$310.4M-560%

Net income-$347.2M-160%

EPS (diluted)-$1.06-185%

Balance sheet

See full

Cash & equivalents$1.1B+64.0%

Total debt$2.2B+82.8%

Total equity-$1.3B-323%

Total assets$3.1B+88.9%

Cash flow

See full

Operating cash flow$249.9M+655%

CapEx$389.2M+363%

Free cash flow-$139.3M-8.0%

Valuation

See full

Market cap$9.27B+121%

Enterprise value$10.28B+119%

P/S26.1×+15.9×

Profitability

See full

Gross margin16.9%+4.3pp

Operating margin-144.7%-478pp

Net margin-238.9%-1.8pp

FCF margin-130%-246pp

Returns & leverage

See full

Return on equity-242.4%—

Debt / equity2.2×—

Current ratio0.5×-3.7×

Where this comes from

Reported directly by Core Scientific, Inc. in its filing.

Tagged under the XBRL concept core:FairValueAdjustmentContingentValueRightsNoncashAdjustment.

The official record: Core Scientific, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Core Scientific, Inc.'s change in fair value of contingent value rights.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Core Scientific, Inc.'s change in fair value of contingent value rights?: Core Scientific, Inc. (CORZ) reported change in fair value of contingent value rights of -$1.04M in Q1 2026.
How has Core Scientific, Inc.'s change in fair value of contingent value rights changed year-over-year?: Core Scientific, Inc.'s change in fair value of contingent value rights decreased by 108.1% year-over-year, from $12.82M to -$1.04M.